Skip to content

Effect of etomidate anesthesia on the immune defense function of neutrophils

Effect of etomidate anesthesia on the immune defense function of neutrophils

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123787
Enrollment
Unknown
Registered
2026-04-29
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative infection-related complications

Interventions

Etoimidate Group:During general anaesthesia, intravenous anaesthesia was administered using etomidate.
Propofol group:During general anaesthesia, propofol is administered intravenously as the anaesthetic agent.

Sponsors

Yongchuan Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Elective surgery, to be performed under general anaesthesia with endotracheal intubation. Patients aged 18–75 years with an ASA II–III. 2.The anticipated duration of the procedure is not expected to exceed three hours. Significant blood loss and the need for transfusion therapy are not anticipated. 3.The patient and their family members were fully informed about the research content and voluntarily participated in and cooperated with the study.

Exclusion criteria

Exclusion criteria: 1.Patients with combined immune disorders or undergoing immunotherapy, or currently receiving radiotherapy and chemotherapy; 2.Concurrent haematological disorders or haematopoietic dysfunction, with abnormal neutrophil counts and percentage distribution; 3.malignant tumour patients; 4.Patients with evident systemic or localised infection; 5.Patients requiring high-dose corticosteroids during anaesthesia and surgery;

Design outcomes

Primary

MeasureTime frame
Phagocytic function;degranulation functionreactive ;oxygen species production;extracellular domain shedding;

Countries

China

Contacts

Public ContactShouyong Wang

Yongchuan Hospital of Chongqing Medical University

wangshyong@126.com+86 23 85381667

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026